3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Octreotide
5
Everolimus
4
pasireotide
3
lanreotide
3
ganitumab
2
gallium Ga 68 dotatate
2
cabozantinib
2
Nivolumab
2
Erlotinib Hydrochloride
2
surufatinib
1
pertuzumab
1
nintedanib
1
ibrutinib
1
fosbretabulin
1
conatumumab
1
cixutumumab
1
carfilzomib
1
arginyllysine
1
aflibercept
1
Temozolomide
1
Sunitinib
1
Somatostatin
1
Random Allocation
1
Ramucirumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Capecitabine
1
Bevacizumab
1
Axitinib
1
(18F)GTP1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoid Tumor
×
Immunotherapy
×
Clear all
No trials found.